Skip to main content
. 2017 Dec 21;23(47):8395–8404. doi: 10.3748/wjg.v23.i47.8395

Table 3.

Comparison of the complete symptom resolution rates between dexlansoprazole and esomeprazole over one week (Subgroup analysis by gender) n (%)

Time Gender Dexlansoprazole Esomeprazole P value
CSR Day 1 Female 13 (27.7) 6 (15.8) 0.192
Male 8 (23.5) 17 (39.5) 0.136
CSR Day 3 Female 18 (38.3) 7 (18.4) 0.046
Male 9 (26.5) 19 (44.2) 0.109
CSR Day 7 Female 26 (55.3) 14 (36.8) 0.090
Male 16 (47.1) 25 (58.1) 0.333

CSR: Complete symptom resolution.